World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
13656
World Ranking
2262
National Ranking
1093

Alan S. Cross publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alan S. Cross sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 234 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Alan S. Cross D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alan S. Cross sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Alan S. Cross is affiliated with the University of Maryland, Baltimore, in the United States. Their research predominantly spans the fields of Biochemistry, Genetics and Molecular Biology as well as Medicine. Within these areas, they have contributed to specialized subfields including Epidemiology, Molecular Medicine, Molecular Biology, Immunology, and Endocrinology.

Their published work addresses multiple topics with a notable focus on Antibiotic Resistance in Bacteria and Pneumonia and Respiratory Infections. Additional topics of study include Bacterial biofilms and quorum sensing, Immune Response and Inflammation, Infant Nutrition and Health, Burn Injury Management and Outcomes, and Escherichia coli research studies.

Among their frequently published venues are Vaccines, Scientific Reports, Infection and Immunity, mBio, and The Journal of Infectious Diseases. These platforms have hosted numerous contributions by Alan S. Cross across their research areas.

Recent papers by Alan S. Cross demonstrate work in infectious disease microbiology and vaccine research, including:

  • The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection, 2020, Frontiers in Microbiology
  • Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection, 2022, BMC Microbiology
  • Vaccine value profile for Klebsiella pneumoniae, 2024, Vaccine
  • Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines, 2021, Vaccines
  • MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection, 2021, Scientific Reports

Collaboration is a significant aspect of their research approach, with frequent co-authors including Sharon M. Tennant, Myeongjin Choi, Raphael Simon, Scott M. Baliban, and Surekha Shridhar. These partnerships have contributed to the development and dissemination of work across related scientific questions and challenges.

Best Publications

  • Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.

    M. Berger;J. O'Shea;A. S. Cross;T. M. Folks

  • Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

    Aaron P Rapoport;Edward A Stadtmauer;Nicole Aqui;Ashraf Badros

  • The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

    Kwang Sik Kim;Hideo Itabashi;Peter Gemski;Jerald Sadoff

  • Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

    A S Cross;J C Sadoff;N Kelly;E Bernton

  • Choice of bacteria in animal models of sepsis

    A S Cross;S M Opal;J C Sadoff;P Gemski

  • Efficacy of a Monoclonal Antibody Directed against Tumor Necrosis Factor in Protecting Neutropenic Rats from Lethal Infection with Pseudomonas aeruginosa

    Steven M. Opal;Alan S. Cross;Niamh M. Kelly;Jerald C. Sadoff

  • Febrile core temperature is essential for optimal host defense in bacterial peritonitis.

    Qinqqi Jiang;Alan S. Cross;Ishwar S. Singh;T. Timothy Chen

  • Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

    Michael Boeckh;Michael Boeckh;Janet Englund;Janet Englund;Yufeng Li;Carole Miller

  • Gamma Interferon Augments Macrophage Activation by Lipopolysaccharide by Two Distinct Mechanisms, at the Signal Transduction Level and via an Autocrine Mechanism Involving Tumor Necrosis Factor Alpha and Interleukin-1

    Thomas K. Held;Xiao Weihua;Liang Yuan;Dhananjaya V. Kalvakolanu

  • Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends

    Alan Cross;James R. Allen;John Burke;Georges Ducel

  • CLINICAL TRIALS FOR SEVERE SEPSIS: Past Failures, and Future Hopes

    Steven M. Opal;Alan S. Cross

  • Inflammatory Cytokines Produced in Response to Experimental Human Gonorrhea

    Kyle H. Ramsey;Herman Schneider;Alan S. Cross;John W. Boslego

  • The Importance of the K1 Capsule in Invasive Infections Caused by Escherichia coli

    Alan S. Cross;Peter Gemski;Jerald C. Sadoff;Frits Ørskov

  • TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia

    Ping Gong;Daniel J. Angelini;Shiqi Yang;Guanjun Xia

  • Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

    Aaron P. Rapoport;Nicole A. Aqui;Edward A. Stadtmauer;Dan T. Vogl

  • Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP.

    D L Hoover;A M Friedlander;L C Rogers;I K Yoon

  • The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli.

    A. Cross;L. Asher;M. Seguin;Liang Yuan

  • Gene expression profiles differentiate between sterile SIRS and early sepsis.

    Steven B. Johnson;Matthew Lissauer;Grant V. Bochicchio;Richard Moore

  • Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells

    Aaron P. Rapoport;Nicole A. Aqui;Edward A. Stadtmauer;Dan T. Vogl

  • Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice.

    Wenju Lu;Akinori Hisatsune;Takeshi Koga;Takeshi Koga;Kosuke Kato;Kosuke Kato

  • Murine Macrophages Kill the Vegetative Form of Bacillus anthracis

    Tae Jin Kang;Matthew J. Fenton;Matthew A. Weiner;Stephen Hibbs

Frequent Co-Authors

Steven M. Opal
Steven M. Opal Brown University
Jerald C. Sadoff
Jerald C. Sadoff Janssen (Belgium)
Stanley J. Cryz
Stanley J. Cryz University of Massachusetts Chan Medical School
Jeffrey D. Hasday
Jeffrey D. Hasday University of Maryland, Baltimore
Wendell D. Zollinger
Wendell D. Zollinger Walter Reed Army Institute of Research
Dhananjaya V. Kalvakolanu
Dhananjaya V. Kalvakolanu University of Maryland, Baltimore
Stefanie N. Vogel
Stefanie N. Vogel University of Maryland, Baltimore
Gerald M. Rosen
Gerald M. Rosen University of Maryland, Baltimore
Erik P. Lillehoj
Erik P. Lillehoj University of Maryland, Baltimore
Lai-Xi Wang
Lai-Xi Wang University of Maryland, College Park

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their expertise in immunology, exploring related online degrees can open numerous career pathways in healthcare and research. Programs like an nurse practitioner accelerated program offer a fast-track route for professionals aiming to become nurse practitioners, combining rigorous training with flexible online study options.

Registered nurses without a prior nursing background can also kickstart their careers through online RN programs for non nurses in Florida, which provide foundational knowledge essential for patient care and immunology-related clinical roles.

For those already holding family nurse practitioner credentials, transitioning to specialized fields via an FNP to acute care NP bridge program can enhance skills applicable to more acute and critical care settings, often intersecting with immunology in managing complex conditions.

Understanding financial prospects is also crucial when choosing your educational path. Insights on earnings, such as how much does a DNP make, reveal that advanced degrees in nursing and health sciences typically lead to improved salary potential, making investment in education worthwhile.

Best Scientists Citing Alan S. Cross

Trending Scientists

Recently Published Articles